Cargando…

Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention

Preventing new HIV infections remains a global challenge. Young women continue to bear a disproportionate burden of infection. Oral pre-exposure prophylaxis (PrEP), offers a novel women-initiated prevention technology and PrEP trials completed to date underscore the importance of their inclusion ear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Quarraisha Abdool, Archary, Derseree, Barré-Sinoussi, Françoise, Broliden, Kristina, Cabrera, Cecilia, Chiodi, Francesca, Fidler, Sarah J., Gengiah, Tanuja N., Herrera, Carolina, Kharsany, Ayesha B. M., Liebenberg, Lenine J. P., Mahomed, Sharana, Menu, Elisabeth, Moog, Christiane, Scarlatti, Gabriella, Seddiki, Nabila, Sivro, Aida, Cavarelli, Mariangela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763292/ https://www.ncbi.nlm.nih.gov/pubmed/36561760 http://dx.doi.org/10.3389/fimmu.2022.1055042

Ejemplares similares

Higher mucosal antibody concentrations in women with genital tract inflammation
por: Sobia, Parveen, et al.
Publicado: (2021)

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
por: Mahomed, Sharana, et al.
Publicado: (2020)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision
por: Humphries, Hilton, et al.
Publicado: (2022)

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
por: Mahomed, Sharana, et al.
Publicado: (2023)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model
por: Cromarty, Ross, et al.
Publicado: (2019)

Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model
por: Cromarty, Ross, et al.
Publicado: (2021)

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
por: Mahomed, Sharana, et al.
Publicado: (2022)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
por: Mansoor, Leila E., et al.
Publicado: (2022)

Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women
por: Mngomezulu, Khanyisile, et al.
Publicado: (2021)

Bridging the gap between science and policy in global health governance
por: Nay, Olivier, et al.
Publicado: (2022)

Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection
por: Jewanraj, Janine, et al.
Publicado: (2021)

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women
por: Mazibuko-Motau, Noluthando, et al.
Publicado: (2022)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Research training experience of Vietnamese health sciences undergraduates visiting the Centre for the AIDS Programme of Research in South Africa
por: Taylor-Robinson, Andrew William, et al.
Publicado: (2023)

Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets
por: Qulu, Wenkosi Perez, et al.
Publicado: (2023)

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage
por: Archary, Derseree, et al.
Publicado: (2015)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men
por: Pillay, Thevani, et al.
Publicado: (2019)

Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products
por: Happel, Anna-Ursula, et al.
Publicado: (2022)

The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract
por: Jewanraj, Janine, et al.
Publicado: (2020)

Plasmodium falciparum Infection Significantly Impairs Placental Cytokine Profile in HIV Infected Cameroonian Women
por: Kfutwah, Anfumbom, et al.
Publicado: (2009)

Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis
por: Mtshali, Andile, et al.
Publicado: (2021)

Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa( )
por: Samsunder, Natasha, et al.
Publicado: (2022)

Enhancing oral PrEP uptake among adolescent girls and young women in Africa
por: Heck, Craig J., et al.
Publicado: (2022)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

Putting women in the centre of the global HIV response is key to achieving epidemic control!
por: Abdool Karim, Quarraisha, et al.
Publicado: (2020)

Adolescent girls and young women: key populations for HIV epidemic control
por: Dellar, Rachael C, et al.
Publicado: (2015)

Proteasome-independent degradation of HIV-1 in naturally non-permissive human placental trophoblast cells
por: Ross, Anna Laura, et al.
Publicado: (2009)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa
por: Ebrahim, Sumayyah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q99oms6le909abkiqqn605qf95